£685 / $1095 / €820
These days we all suffer from information overload; by focusing specifically on cancer drugs, the Cancer Drug News online service will deliver the information you need in a timely, flexible and convenient format.
Monitoring business developments in world anticancer drug markets is becoming more and more vital. Investigators continue to uncover the molecular basis of cancer, increasing the possibility of personalised treatment for this heterogeneous disease. Biopharmaceuticals are increasingly taking centre stage in clinical and research efforts, but established products, often spurned in new combination therapies, continue to be the front-line clinical choice in many cancers. The challenges and opportunities for companies and clinicians are considerable.
For pharmaceutical company executives, researchers and commercial managers, staying in touch with the latest twists and turns is another matter. That is why Cancer Drug News is essential.
The Cancer Drug News online service provides unbeatable coverage:
Every day, Espicom’s researchers and editors
The Cancer Drug News online information service is updated regularly. Cancer Drug News also available in pdf format, providing a weekly digest (min. 44 issues per year) of the news published online.
Cost-effective multi-user distribution deals means the service can be used widely by colleagues in your organisation – contact firstname.lastname@example.org for details.